Apr. 3, 2017
n April 3, 2017, Lombard Medical, Inc., a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation, a leading global manufacturer and marketer of a diversified portfolio of medical devices, announced their agreement to form a strategic partnership.
The partnership will allow Lombard to accelerate commercialization in China and other global markets for its abdominal aortic aneurysms (AAA) product portfolio.
MicroPort will manufacture, in its facilities in Shanghai, certain components for the Lombard’s Aorfix and Altura product lines. It is anticipated that MicroPort will begin providing components to Lombard in the second half of 2017.
MicroPort has the exclusive marketing rights for the Lombard product portfolio for China and Brazil as well as a technology license to manufacture the products for the Chinese market. MicroPort expects to launch Aorfix in China after gaining CFDA approval which is anticipated in the second half of 2018.